Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice

By Hashem Fahima M.  

Pharmaceutical Development and Technology, Vol. 18, Iss. 5, 2013-10 ,pp. : 1175-1185

Informa Healthcare

Access to resources Recommend Favorite

Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus

By  

Current Drug Delivery, Vol. 14, Iss. 5, 2017-07 ,pp. : 701-708

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and Opportunities for Cancer Vaccines in the Current NSCLC Clinical Scenario

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 20, 2013-10 ,pp. : 2551-2561

Bentham Science Publishers

Access to resources Recommend Favorite

Preventive and Therapeutic Vaccines Against Helicobacter Pylori: Current Status and Future Challenges

By  

Current Pharmaceutical Design, Vol. 6, Iss. 15, 2000-10 ,pp. : 1557-1573

Bentham Science Publishers

Access to resources Recommend Favorite

Intranasal Cold-Adapted Influenza Virus Vaccine Combined with Inactivated Influenza Virus Vaccines: An Extra Boost for the Elderly?

By Targonski P.V.   Poland G.A.  

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 349-359

Adis International

Access to resources Recommend Favorite